Znn3bq.jpeg
²é¿´: 402  |  »Ø¸´: 1
±¾Ìû²úÉú 1 ¸ö £¬µã»÷ÕâÀï½øÐв鿴

xiandongzeng

ľ³æ (ÕýʽдÊÖ)

[ÇóÖú] WOSÈë²ØºÅÇóÖú

WOSÈë²ØºÅÇóÖú£ºNext-generation sequencing reveals lymph node metastasis associated genetic markers in colorectal cancer£¬Experimental & Therapeutic Medicine , 2017 , 14 (1) :338¡£

» ²ÂÄãϲ»¶

ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

baiyuefei

°æÖ÷ (ÎÄѧ̩¶·)

·çÑ©

ÓÅÐã°æÖ÷ÓÅÐã°æÖ÷ÓÅÐã°æÖ÷ÎÄÏ׽ܳö¹±Ï×ÓÅÐã°æÖ÷ÓÅÐã°æÖ÷ÓÅÐã°æÖ÷ÎÄÏ׽ܳö¹±Ï×ÓÅÐã°æÖ÷ÓÅÐã°æÖ÷ÓÅÐã°æÖ÷ÓÅÐã°æÖ÷ÎÄÏ׽ܳö¹±Ï×ÓÅÐã°æÖ÷ÓÅÐã°æÖ÷ÓÅÐã°æÖ÷ÓÅÐã°æÖ÷ÓÅÐã°æÖ÷ÓÅÐã°æÖ÷

¡¾´ð°¸¡¿Ó¦Öú»ØÌû

¡ï ¡ï ¡ï ¡ï ¡ï
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
xiandongzeng: ½ð±Ò+5, ¡ï¡ï¡ï¡ï¡ï×î¼Ñ´ð°¸, 3Ks 2018-09-18 09:15:12
Ðľ²_ÒÀÈ»: LS-EPI+1, ¸ÐлӦÖú 2018-09-19 08:38:11
Next-generation sequencing reveals lymph node metastasis associated genetic markers in colorectal cancer
×÷Õß:Xie, N (Xie, Ni)[ 1 ] ; Yao, YJ (Yao, Yujiang)[ 1 ] ; Wan, LL (Wan, Lili)[ 1 ] ; Zhu, T (Zhu, Ting)[ 1 ] ; Liu, LT (Liu, Litao)[ 1 ] ; Yuan, JH (Yuan, Jianhui)[ 2 ]

EXPERIMENTAL AND THERAPEUTIC MEDICINE

¾í: 14  ÆÚ: 1  Ò³: 338-343  ×Ó¼­: A
DOI: 10.3892/etm.2017.4464

³ö°æÄê:JUL 2017

ÎÄÏ×ÀàÐÍ:Article

²é¿´ÆÚ¿¯Ó°ÏìÁ¦

ÕªÒª
Colorectal cancer is the third most prevalent type of cancer in the United States. Early diagnosis of lymph node metastases is essential to improve the prognosis for patients with colorectal cancer. Therefore, the present study aimed to screen genetic markers, including single nucleotide polymorphisms (SNPs), copy number variations (CNVs) and mRNA expression, associated with lymph node metastases in patients with colorectal cancer to enable an early diagnosis. Targeted next-generation sequencing was applied to capture SNPs and CNVs in tumor-related candidate genes within tumor tissues from 39 colorectal cancer patients; reverse transcription-quantitative polymerase chain reaction was used to detect the specific mRNA level of tumor-related candidate genes, including vascular endothelial growth factor C, cyclin-A2, Interleukin-2, ATP-binding cassette sub-family G member 2, epidermal growth factor (EGF) and nuclear factor kappa B subunit 1 (NFKB1) on chromosome 4. The SNPs in solute carrier family 28 member 3 (SLC28A3), breast cancer 1 (BRCA1), ribonucleotide reductase regulators subunit M2 (RRM2), PMS1 homolog 2 (PMS2), cytidine deaminase (CDA), epoxide hydrolase 1 (EPHX1), heterogenous ribonucleoprotein particle-associated with lethal yellow (RALY), Siglec-3 (CD33), B cell lymphoma 10 (BCL10), ETS variant 1 (ETV1), macrophage stimulating 1 receptor 1 (MST1R), lysine methyltransferase 2B (KMT2B), B cell lymphoma 2 (BCL2), U6 small nuclear RNA -associated Sm-like protein 3 (LSM3), thyroid transcription factor 1 (TTF1) and mitogen-activated protein 3 kinase 1 (MAP3K1) were significantly associated with lymphatic metastasis (P<0.05). EGF and NFKB1 were both observed to be significantly downregulated in the lymph node metastases group (P<0.05). Although no association between CNVs and lymph node metastases in patients with colorectal cancer was observed in the present study, SNPs in SLC28A3, BRCA1, RRM2, PMS2, CDA, EPHX1, RALY, CD33, BCL10, ETV1, MST1R, KMT2B, BCL2, LSM3, TTF1 and MAP3K1 were significantly associated with colorectal cancer. Downregulation of EGF and NFKB1 was also identified to be associated with lymph node metastases in colorectal cancer. The findings of the current study provide a scientific basis for the clinical inspection of lymphatic metastasis and prognosis prediction, intervention and guidance therapy for patients with colorectal cancer.

¹Ø¼ü´Ê
×÷Õ߹ؼü´Ê:copy number variation; single nucleotide polymorphisms; colorectal cancer; lymph node metastasis

KeyWords Plus:COMPARATIVE GENOMIC HYBRIDIZATION; RECTAL-CANCER; OPPORTUNITIES; PATHOGENESIS; TRANSITION; PATHWAYS

×÷ÕßÐÅÏ¢
ͨѶ×÷ÕßµØÖ·: Yuan, JH (ͨѶ×÷Õß)

              Shenzhen Ctr Dis Control & Prevent, Sci & Educ Adm Dept, 8 Longyuan Rd, Shenzhen 518055, Guangdong, Peoples R China.
µØÖ·:

ÏÔʾ¸ü¶à        [ 1 ] Shenzhen Second Peoples Hosp, Sci & Educ Adm Dept, Shenzhen 518000, Guangdong, Peoples R China
              [ 2 ] Shenzhen Ctr Dis Control & Prevent, Sci & Educ Adm Dept, 8 Longyuan Rd, Shenzhen 518055, Guangdong, Peoples R China
µç×ÓÓʼþµØÖ·:jianhui_yuan@126.com

»ù½ð×ÊÖúÖÂл
»ù½ð×ÊÖú»ú¹¹        ÊÚȨºÅ
Project of Basic Research Plan Program of Shenzhen        
JCYJ20160328161613864
Innovation Program of Shenzhen        
JCYJ20150330102720122
Project of Shenzhen Basic Development Program        
JCYJ20120613171430264
JCYJ20130329110928684
Project of Shenzhen International Cooperation Foundation        
GJHZ20130412153906740
GJHZ20160301163138685
Nature Science Foundation of Guangdong        
2016A030313029
Project of Guangdong Scientific Plan Foundation        
2013B021800097
2014A020212038
²é¿´»ù½ð×ÊÖúÐÅÏ¢   
³ö°æÉÌ
SPANDIDOS PUBL LTD, POB 18179, ATHENS, 116 10, GREECE

Àà±ð / ·ÖÀà
Ñо¿·½Ïò:Research & Experimental Medicine

Web of Science Àà±ð:Medicine, Research & Experimental

ÎÄÏ×ÐÅÏ¢
ÓïÑÔ:English

Èë²ØºÅ: WOS:000405645400050

PubMed ID: 28672935

ISSN: 1792-0981

eISSN: 1792-1015

ÆäËûÐÅÏ¢
IDS ºÅ: FA7RU

Web of Science ºËÐĺϼ¯ÖÐµÄ "ÒýÓõIJο¼ÎÄÏ×": 26

Web of Science ºËÐĺϼ¯ÖÐµÄ "±»ÒýƵ´Î": 2
2Â¥2018-09-18 08:46:31
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
Ïà¹Ø°æ¿éÌø×ª ÎÒÒª¶©ÔÄÂ¥Ö÷ xiandongzeng µÄÖ÷Ìâ¸üÐÂ
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] ²ÄÁÏÀà284µ÷¼Á +40 Ïë»»ÊÖ»ú²»Ïë½âÊ 2026-04-08 48/2400 2026-04-10 23:28 by 314126402
[¿¼ÑÐ] 0703µ÷¼Á +19 ʰ¾ÁÒ¼ 2026-04-04 22/1100 2026-04-10 22:16 by bljnqdcc
[¿¼ÑÐ] 0856ר˶Çóµ÷¼Á Ï£ÍûÊÇaÇøÔºÐ£ +21 ºÃºÃÐÝÏ¢ºÃ²»ºÃ 2026-04-09 24/1200 2026-04-10 16:58 by luoyongfeng
[¿¼ÑÐ] 293µ÷¼Á +25 yj1221 2026-04-08 26/1300 2026-04-10 15:02 by ²ñС°×
[¿¼ÑÐ] Ò»Ö¾Ô¸ÖÐÄÏ´óѧÎïÀíѧ£¬Ó¢Ò»66£¬Çóµ÷¼Á +4 ³¤ÑÌì½ì» 2026-04-08 5/250 2026-04-10 10:31 by Ó±¹û¶ù
[¿¼ÑÐ] ÉúÎïÓëÒ½Ò©µ÷¼Á +5 Ê®Æßsa 2026-04-05 5/250 2026-04-10 08:14 by kangsm
[¿¼ÑÐ] Ò»Ö¾Ô¸»ª¹¤085600 331·Ö +6 ÌìÏÂww 2026-04-09 6/300 2026-04-09 18:59 by l_paradox
[¿¼ÑÐ] 085501»úеר˶ 302·Ö ²»ÌôרҵÇóµ÷¼Á +5 Íôij. 2026-04-09 5/250 2026-04-09 15:38 by ½¯ð©Óí
[¿¼ÑÐ] 280Çóµ÷¼Á +7 wzzzÍõ 2026-04-09 7/350 2026-04-09 15:32 by ÊÍ·ÅÌìÐÔ
[¿¼ÑÐ] 086000µ÷¼Á +4 Ê®Æßsa 2026-04-07 4/200 2026-04-09 09:27 by Ò¼ÍùŸoǰ
[¿¼ÑÐ] Çóµ÷¼Á +7 chenxrlkx 2026-04-05 9/450 2026-04-09 09:04 by wj165256
[¿¼ÑÐ] 307Çóµ÷¼Á +14 ³¬¼¶ÒÁ°º´óÍõ 2026-04-06 14/700 2026-04-08 07:03 by Î޼ʵIJÝÔ­
[¿¼ÑÐ] ¼ÆËã»ú11408 287 Çóµ÷¼Á +3 LiLe5 2026-04-07 3/150 2026-04-07 23:15 by shanqishi
[¿¼ÑÐ] 285Çóµ÷¼Á +15 ŶßϺôo 2026-04-04 17/850 2026-04-06 23:02 by chenzhimin
[¿¼ÑÐ] 26×ÔÈ»µØÀíѧ303·ÖÇóµ÷¼Á +4 Ò»Õ½³É˶°¡°¡°¡° 2026-04-06 9/450 2026-04-06 20:35 by lin-da
[¿¼ÑÐ] Çóµ÷¼Á +10 chenxrlkx 2026-04-05 10/500 2026-04-06 11:31 by Öí»á·É
[¿¼ÑÐ] 0817»¯Ñ§¹¤³ÌÓë¼¼ÊõÇóµ÷¼Á£¬Ò»Ö¾Ô¸Öк£Ñó319 +14 lv945 2026-04-04 14/700 2026-04-06 10:20 by À¶ÔÆË¼Óê
[¿¼ÑÐ] 348Çóµ÷¼Á +6 wukira 2026-04-04 6/300 2026-04-05 18:11 by Öí»á·É
[¿¼ÑÐ] Ò»Ö¾Ô¸±±½»´ó²ÄÁϹ¤³Ì×Ü·Ö358Çóµ÷¼Á +6 cs0106 2026-04-05 6/300 2026-04-05 16:34 by imissbao
[¿¼ÑÐ] 290Çóµ÷¼Á +7 luoziheng 2026-04-04 7/350 2026-04-04 23:17 by lqwchd
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û